96
Participants
Start Date
August 31, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2027
Pegmolesatide 2mg SC
All patients will receive pegmolesatide 2mg subcutaneously once every 4 weeks.
Pegmolesatide 4mg SC
All patients will receive pegmolesatide 4mg subcutaneously once every 4 weeks.
Pegmolesatide 4mg SC
All patients will receive pegmolesatide 4mg subcutaneously once every 4 weeks.
Pegmolesatide 6mg SC
All patients will receive pegmolesatide 6mg subcutaneously once every 4 weeks.
Guangdong Provincial People's Hospital, Guangzhou
Beijing Hospital, Beijing
Longyan First Hospital, Longyan
Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Meizhou People's Hospital, Meizhou
The First Affiliated Hospital of Shantou University Medical College, Shantou
Yuebei People's Hospital, Shaoguan
Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan
Affiliated Hospital of Zunyi Medical University, Zunyi
Jingmen Central Hospital, Jingmen
CNPG Dongfeng General Hospital, Shiyan
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan
Wuhan Fourth Hospital, Wuhan
Changsha Central Hospital, Changsha
Nantong First People's Hospital, Nantong
The First Hospital of China Medical University, Shenyang
The First Affiliated Hospital of Baotou Medical College, Baotou
The First Affiliated Hospital of Shandong First Medical University, Jinan
Yibin First People's Hospital, Yibin
Tianjin First Center Hospital, Tianjin
Hangzhou Xiaoshan First People's Hospital, Hangzhou
The Affiliated People's Hospital of Ningbo University, Ningbo
Rui'an People's Hospital, Wenzhou
Guangdong Provincial People's Hospital
OTHER